Table 2.
Transverse relaxation rates | aWhole data set (n = 36) | No hepcidin treatment (n = 25) | Hepcidin treatment (n = 11) | Difference between slopes | ||||
---|---|---|---|---|---|---|---|---|
br | r | bβ | r2 | r | β | r2 | ||
R2* |
0.607 p < 0.001 |
0.629 p < 0.001 |
10.09 | 0.396 |
0.851 p < 0.001 |
35.36 | 0.724 | p < 0.05 |
R2 |
0.468 p < 0.01 |
0.473 p < 0.01 |
5.25 | 0.224 |
0.866 p < 0.001 |
27.77 | 0.750 | p < 0.01 |
0.679 p < 0.001 |
0.719 p < 0.001 |
4.84 | 0.517 |
0.532 p < 0.05 |
cn.s. | n.s. | cn/a |
aStatistical analysis of the whole data set combines samples treated with (n = 11) and without (n = 25) hepcidin. n, sample size.
br, Pearson correlation coefficient; p, level of significance; β, linear regression slope.
cn.s., not significant; n/a, not applicable.